INCANNEX HEALTHCARE LIMITED - Announcements

0.00%

4.1¢

Currently unlisted.

Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical... Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical development company. The Company is focused on developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of generalized anxiety disorder (GAD), obstructive sleep apnea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation, rheumatoid arthritis and inflammatory bowel disease. Its drug candidates include IHL-42X, IHL-216A and HL-675A. Its IHL-42X is a combination of acetazolamide and dronabinol for treatment of OSA. Its IHL-216A is a combination of isoflurane and cannabidiol (CBD) to prevent development of TBI/concussion. Its HL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. It is also investigating the use of psilocybin assisted psychotherapy to treat GAD.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Announcements

Filter Results

All Price Sensitive Only

IHL	Implementation of Schemes		29/11/23	138.95KB	Share
IHL	Removal from Official List		29/11/23	86.91KB	Share
IHL	Shareholder Support and Instructions	PRICE SENSITIVE	23/11/23	890.3KB	Share
IHL	Suspension from Official Quotation	PRICE SENSITIVE	17/11/23	87.01KB	Share
IHL	Computershare to be Appointed as US Transfer Agent	PRICE SENSITIVE	17/11/23	172.32KB	Share
IHL	Schemes become Effective	PRICE SENSITIVE	17/11/23	6.95MB	Share
IHL	Court Approves Schemes	PRICE SENSITIVE	16/11/23	218.53KB	Share
IHL	Results of Scheme Meetings	PRICE SENSITIVE	08/11/23	375.02KB	Share
IHL	Change of Director's Interest Notice x2		07/11/23	501.67KB	Share
IHL	Incannex Files Form 20F with SEC		02/11/23	144.44KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/10/23	574.83KB	Share
IHL	Voting Update for Incannex to Redomicile to United States		19/10/23	883.38KB	Share
IHL	Cleansing Statement		12/10/23	66.03KB	Share
IHL	Application for quotation of securities - IHL		12/10/23	24.85KB	Share
IHL	Scheme Booklet Dispatched		10/10/23	1.79MB	Share
IHL	IHL SCHEME BOOKLET REGISTERED WITH ASIC	PRICE SENSITIVE	05/10/23	11.52MB	Share
IHL	IHL Announces - Results of First Court Hearing	PRICE SENSITIVE	05/10/23	205.69KB	Share
IHL	Incannex to Present at the H.C. Wainwright Conference		08/09/23	148.22KB	Share
IHL	S&P DJI Announces September 2023 Quarterly Rebalance	PRICE SENSITIVE	01/09/23	121.59KB	Share
IHL	Appendix 4G		01/09/23	265.42KB	Share
IHL	Clarification to Top 20 in Annual Report		30/08/23	205.43KB	Share
IHL	Annual Report and Appendix 4E	PRICE SENSITIVE	30/08/23	2.25MB	Share
IHL	Incannex to Prepare IND Application for Psi-GAD	PRICE SENSITIVE	24/08/23	160.28KB	Share
IHL	US FDA Completes Review of IHL-42x IND Application	PRICE SENSITIVE	22/08/23	194.22KB	Share
IHL	IHL Provides Shareholder Information Events for Redomiciling		10/08/23	146.92KB	Share
IHL	Change of Director's Interest Notice		09/08/23	144.89KB	Share
IHL	Psychedelic Treatment Registrations start at Clarion Clinics	PRICE SENSITIVE	08/08/23	196.9KB	Share
IHL	Incannex Provides Access to Advisory Firm for Redomicile		01/08/23	148.2KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	375.41KB	Share
IHL	IHL Completes Pre-IND Meeting with US FDA on IHL-675A	PRICE SENSITIVE	26/07/23	195.02KB	Share
IHL	IHL Submit IND Application for IHL42x	PRICE SENSITIVE	21/07/23	202.39KB	Share
IHL	Fortrea to Manage IHL FDA IND Phase 2 and 3 Clinical Trial	PRICE SENSITIVE	18/07/23	175.25KB	Share
IHL	IHL Receives HREC Approval Ph 2 Clinical Trial for IHL675	PRICE SENSITIVE	13/07/23	231.08KB	Share
IHL	Updated IHL Intends to Redomicile to US announcement - SID	PRICE SENSITIVE	10/07/23	1.04MB	Share
IHL	IHL Intends to Redomicile to US & List all Shares on Nasdaq	PRICE SENSITIVE	10/07/23	190.95KB	Share
IHL	IHL Receives Ethics Approval BA/BE Clinical Trial.	PRICE SENSITIVE	06/07/23	137.97KB	Share
IHL	Change of Director's Interest Notice		30/06/23	527.15KB	Share
IHL	Change of Registered Office		26/06/23	167.88KB	Share
IHL	IHL Announcement - H.C. Wainwright Virtual Conference		23/06/23	148.29KB	Share
IHL	Principal Investigators Appointed for IHL42X Phase 2/3 Trial	PRICE SENSITIVE	16/06/23	204.62KB	Share
IHL	Change of Director's Interest Notice		06/06/23	472.17KB	Share
IHL	Notification regarding unquoted securities - IHL		02/06/23	23.76KB	Share
IHL	International Psychedelics Experts Join Clarion Clinics		30/05/23	238.02KB	Share
IHL	Entitlement Offer of Loyalty Options Oversubscribed	PRICE SENSITIVE	30/05/23	171.71KB	Share
IHL	Psychennex Pty Ltd - Company Update	PRICE SENSITIVE	16/05/23	13.68MB	Share
IHL	Lease Secured for Psychedelic Clinic	PRICE SENSITIVE	05/05/23	153.35KB	Share
IHL	IHL-675A Phase 1 Results Presentation	PRICE SENSITIVE	03/05/23	3.64MB	Share
IHL	Non-Renounceable Issue	PRICE SENSITIVE	03/05/23	407.09KB	Share
IHL	Incannex Announces Final Results from Phase 1 Clinical Trial		02/05/23	245.19KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/04/23	371.61KB	Share
IHL	Proposed issue of securities - IHL		26/04/23	29.24KB	Share
IHL	Cancel - Proposed issue of securities - IHL		24/04/23	32.58KB	Share
IHL	Proposed issue of securities - IHL		21/04/23	32.95KB	Share
IHL	Entitlement Offer of Loyalty Options	PRICE SENSITIVE	21/04/23	189.44KB	Share
IHL	Global CRO leader QPS engaged for CannQuit & ReneCann	PRICE SENSITIVE	14/04/23	169.07KB	Share
IHL	Incannex Launches Psychedelic Clinics Business	PRICE SENSITIVE	16/03/23	213.38KB	Share
IHL	Reinstatement to Official Quotation	PRICE SENSITIVE	15/03/23	86.03KB	Share
IHL	Interim phase 2 PsiGAD psilocybin results	PRICE SENSITIVE	15/03/23	206.28KB	Share
IHL	Voluntary Suspension	PRICE SENSITIVE	14/03/23	203.88KB	Share
IHL	Trading Halt	PRICE SENSITIVE	10/03/23	201.72KB	Share
IHL	Pause in Trading	PRICE SENSITIVE	10/03/23	116.66KB	Share
IHL	Incannex to Manufacture Psilocybin for Trials & Commercial	PRICE SENSITIVE	03/03/23	170.48KB	Share
IHL	IHL Commences Phase 2 Clinical Trial	PRICE SENSITIVE	28/02/23	217.14KB	Share
IHL	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	27/02/23	831.87KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/01/23	313.9KB	Share
IHL	Independent data review commences for Ph 2 trial psilocybin	PRICE SENSITIVE	18/01/23	147.05KB	Share
IHL	Appendix 3Y R Clark		28/12/22	223.92KB	Share
IHL	Notification regarding unquoted securities - IHL		16/12/22	25.17KB	Share
IHL	Proposed issue of securities - IHL		15/12/22	29.85KB	Share
IHL	Cleansing Statement		09/12/22	66.95KB	Share
IHL	Notification regarding unquoted securities - IHL		09/12/22	23.58KB	Share
IHL	Application for quotation of securities - IHL		09/12/22	24.68KB	Share
IHL	Incannex Expands Intellectual Property Position over IHL-42X	PRICE SENSITIVE	06/12/22	160.22KB	Share
IHL	Prospectus for Placement Options	PRICE SENSITIVE	05/12/22	490.64KB	Share
IHL	Proposed issue of securities - IHL		05/12/22	28KB	Share
IHL	Capital Raising Presentation	PRICE SENSITIVE	05/12/22	2.63MB	Share
IHL	Incannex Undertakes A$13 Million Institutional Placement	PRICE SENSITIVE	05/12/22	170.54KB	Share
IHL	Trading Halt	PRICE SENSITIVE	01/12/22	199.72KB	Share
IHL	Results of Meeting		29/11/22	160.03KB	Share
IHL	IHL Annual General Meeting CEO Address	PRICE SENSITIVE	29/11/22	153.68KB	Share
IHL	IHL commences manufacturing of skin therapeutics	PRICE SENSITIVE	29/11/22	149.66KB	Share
IHL	IHL Commences Manufacturing for Novel Addiction Treatments	PRICE SENSITIVE	25/11/22	184.92KB	Share
IHL	Addendum to Notice of Annual General Meeting		21/11/22	579.58KB	Share
IHL	Incannex Development Update for IHL-42X	PRICE SENSITIVE	17/11/22	168.4KB	Share
IHL	Incannex files Form 20-F and XBRL Data with SEC		31/10/22	144.97KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/22	382.8KB	Share
IHL	Notice of Annual General Meeting/Proxy Form		21/10/22	510.37KB	Share
IHL	Application for quotation of securities - IHL		14/10/22	24.78KB	Share
IHL	Positive preliminary data from IHL-675A Ph 1 trial	PRICE SENSITIVE	13/10/22	193.35KB	Share
IHL	Positive Pre-IND Meeting with US FDA on IHL-216A	PRICE SENSITIVE	11/10/22	147.35KB	Share
IHL	Annual General Meeting Date		07/10/22	138.04KB	Share
IHL	Appendix 4G		20/09/22	263.2KB	Share
IHL	Annual Report		20/09/22	18MB	Share
IHL	Incannex Presenting at H.C. Wainwright Global Conference		08/09/22	148.95KB	Share
IHL	Incannex Included in the S&P/ASX 300 Index		06/09/22	148KB	Share
IHL	S&P DJI Announces September 2022 Quarterly Rebalance	PRICE SENSITIVE	02/09/22	134KB	Share
IHL	Appendix 4E & Unaudited Accounts for Year Ended 30 June 2022	PRICE SENSITIVE	31/08/22	414.66KB	Share
IHL	Appendix 3Y		26/08/22	275.45KB	Share
IHL	Appendix 3X, Form 605 and Appendix 3Y		19/08/22	731.83KB	Share
IHL	Incannex Appoints Distinguished FDA Expert to Board		17/08/22	159.23KB	Share

IHL Implementation of Schemes
29/11/23		138.95KB	Share
IHL Removal from Official List
29/11/23		86.91KB	Share
IHL Shareholder Support and Instructions
23/11/23	PRICE SENSITIVE	890.3KB	Share
IHL Suspension from Official Quotation
17/11/23	PRICE SENSITIVE	87.01KB	Share
IHL Computershare to be Appointed as US Transfer Agent
17/11/23	PRICE SENSITIVE	172.32KB	Share
IHL Schemes become Effective
17/11/23	PRICE SENSITIVE	6.95MB	Share
IHL Court Approves Schemes
16/11/23	PRICE SENSITIVE	218.53KB	Share
IHL Results of Scheme Meetings
08/11/23	PRICE SENSITIVE	375.02KB	Share
IHL Change of Director's Interest Notice x2
07/11/23		501.67KB	Share
IHL Incannex Files Form 20F with SEC
02/11/23		144.44KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
26/10/23	PRICE SENSITIVE	574.83KB	Share
IHL Voting Update for Incannex to Redomicile to United States
19/10/23		883.38KB	Share
IHL Cleansing Statement
12/10/23		66.03KB	Share
IHL Application for quotation of securities - IHL
12/10/23		24.85KB	Share
IHL Scheme Booklet Dispatched
10/10/23		1.79MB	Share
IHL IHL SCHEME BOOKLET REGISTERED WITH ASIC
05/10/23	PRICE SENSITIVE	11.52MB	Share
IHL IHL Announces - Results of First Court Hearing
05/10/23	PRICE SENSITIVE	205.69KB	Share
IHL Incannex to Present at the H.C. Wainwright Conference
08/09/23		148.22KB	Share
IHL S&P DJI Announces September 2023 Quarterly Rebalance
01/09/23	PRICE SENSITIVE	121.59KB	Share
IHL Appendix 4G
01/09/23		265.42KB	Share
IHL Clarification to Top 20 in Annual Report
30/08/23		205.43KB	Share
IHL Annual Report and Appendix 4E
30/08/23	PRICE SENSITIVE	2.25MB	Share
IHL Incannex to Prepare IND Application for Psi-GAD
24/08/23	PRICE SENSITIVE	160.28KB	Share
IHL US FDA Completes Review of IHL-42x IND Application
22/08/23	PRICE SENSITIVE	194.22KB	Share
IHL IHL Provides Shareholder Information Events for Redomiciling
10/08/23		146.92KB	Share
IHL Change of Director's Interest Notice
09/08/23		144.89KB	Share
IHL Psychedelic Treatment Registrations start at Clarion Clinics
08/08/23	PRICE SENSITIVE	196.9KB	Share
IHL Incannex Provides Access to Advisory Firm for Redomicile
01/08/23		148.2KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	375.41KB	Share
IHL IHL Completes Pre-IND Meeting with US FDA on IHL-675A
26/07/23	PRICE SENSITIVE	195.02KB	Share
IHL IHL Submit IND Application for IHL42x
21/07/23	PRICE SENSITIVE	202.39KB	Share
IHL Fortrea to Manage IHL FDA IND Phase 2 and 3 Clinical Trial
18/07/23	PRICE SENSITIVE	175.25KB	Share
IHL IHL Receives HREC Approval Ph 2 Clinical Trial for IHL675
13/07/23	PRICE SENSITIVE	231.08KB	Share
IHL Updated IHL Intends to Redomicile to US announcement - SID
10/07/23	PRICE SENSITIVE	1.04MB	Share
IHL IHL Intends to Redomicile to US & List all Shares on Nasdaq
10/07/23	PRICE SENSITIVE	190.95KB	Share
IHL IHL Receives Ethics Approval BA/BE Clinical Trial.
06/07/23	PRICE SENSITIVE	137.97KB	Share
IHL Change of Director's Interest Notice
30/06/23		527.15KB	Share
IHL Change of Registered Office
26/06/23		167.88KB	Share
IHL IHL Announcement - H.C. Wainwright Virtual Conference
23/06/23		148.29KB	Share
IHL Principal Investigators Appointed for IHL42X Phase 2/3 Trial
16/06/23	PRICE SENSITIVE	204.62KB	Share
IHL Change of Director's Interest Notice
06/06/23		472.17KB	Share
IHL Notification regarding unquoted securities - IHL
02/06/23		23.76KB	Share
IHL International Psychedelics Experts Join Clarion Clinics
30/05/23		238.02KB	Share
IHL Entitlement Offer of Loyalty Options Oversubscribed
30/05/23	PRICE SENSITIVE	171.71KB	Share
IHL Psychennex Pty Ltd - Company Update
16/05/23	PRICE SENSITIVE	13.68MB	Share
IHL Lease Secured for Psychedelic Clinic
05/05/23	PRICE SENSITIVE	153.35KB	Share
IHL IHL-675A Phase 1 Results Presentation
03/05/23	PRICE SENSITIVE	3.64MB	Share
IHL Non-Renounceable Issue
03/05/23	PRICE SENSITIVE	407.09KB	Share
IHL Incannex Announces Final Results from Phase 1 Clinical Trial
02/05/23		245.19KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
27/04/23	PRICE SENSITIVE	371.61KB	Share
IHL Proposed issue of securities - IHL
26/04/23		29.24KB	Share
IHL Cancel - Proposed issue of securities - IHL
24/04/23		32.58KB	Share
IHL Proposed issue of securities - IHL
21/04/23		32.95KB	Share
IHL Entitlement Offer of Loyalty Options
21/04/23	PRICE SENSITIVE	189.44KB	Share
IHL Global CRO leader QPS engaged for CannQuit & ReneCann
14/04/23	PRICE SENSITIVE	169.07KB	Share
IHL Incannex Launches Psychedelic Clinics Business
16/03/23	PRICE SENSITIVE	213.38KB	Share
IHL Reinstatement to Official Quotation
15/03/23	PRICE SENSITIVE	86.03KB	Share
IHL Interim phase 2 PsiGAD psilocybin results
15/03/23	PRICE SENSITIVE	206.28KB	Share
IHL Voluntary Suspension
14/03/23	PRICE SENSITIVE	203.88KB	Share
IHL Trading Halt
10/03/23	PRICE SENSITIVE	201.72KB	Share
IHL Pause in Trading
10/03/23	PRICE SENSITIVE	116.66KB	Share
IHL Incannex to Manufacture Psilocybin for Trials & Commercial
03/03/23	PRICE SENSITIVE	170.48KB	Share
IHL IHL Commences Phase 2 Clinical Trial
28/02/23	PRICE SENSITIVE	217.14KB	Share
IHL Appendix 4D and Half Year Accounts
27/02/23	PRICE SENSITIVE	831.87KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
27/01/23	PRICE SENSITIVE	313.9KB	Share
IHL Independent data review commences for Ph 2 trial psilocybin
18/01/23	PRICE SENSITIVE	147.05KB	Share
IHL Appendix 3Y R Clark
28/12/22		223.92KB	Share
IHL Notification regarding unquoted securities - IHL
16/12/22		25.17KB	Share
IHL Proposed issue of securities - IHL
15/12/22		29.85KB	Share
IHL Cleansing Statement
09/12/22		66.95KB	Share
IHL Notification regarding unquoted securities - IHL
09/12/22		23.58KB	Share
IHL Application for quotation of securities - IHL
09/12/22		24.68KB	Share
IHL Incannex Expands Intellectual Property Position over IHL-42X
06/12/22	PRICE SENSITIVE	160.22KB	Share
IHL Prospectus for Placement Options
05/12/22	PRICE SENSITIVE	490.64KB	Share
IHL Proposed issue of securities - IHL
05/12/22		28KB	Share
IHL Capital Raising Presentation
05/12/22	PRICE SENSITIVE	2.63MB	Share
IHL Incannex Undertakes A$13 Million Institutional Placement
05/12/22	PRICE SENSITIVE	170.54KB	Share
IHL Trading Halt
01/12/22	PRICE SENSITIVE	199.72KB	Share
IHL Results of Meeting
29/11/22		160.03KB	Share
IHL IHL Annual General Meeting CEO Address
29/11/22	PRICE SENSITIVE	153.68KB	Share
IHL IHL commences manufacturing of skin therapeutics
29/11/22	PRICE SENSITIVE	149.66KB	Share
IHL IHL Commences Manufacturing for Novel Addiction Treatments
25/11/22	PRICE SENSITIVE	184.92KB	Share
IHL Addendum to Notice of Annual General Meeting
21/11/22		579.58KB	Share
IHL Incannex Development Update for IHL-42X
17/11/22	PRICE SENSITIVE	168.4KB	Share
IHL Incannex files Form 20-F and XBRL Data with SEC
31/10/22		144.97KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22	PRICE SENSITIVE	382.8KB	Share
IHL Notice of Annual General Meeting/Proxy Form
21/10/22		510.37KB	Share
IHL Application for quotation of securities - IHL
14/10/22		24.78KB	Share
IHL Positive preliminary data from IHL-675A Ph 1 trial
13/10/22	PRICE SENSITIVE	193.35KB	Share
IHL Positive Pre-IND Meeting with US FDA on IHL-216A
11/10/22	PRICE SENSITIVE	147.35KB	Share
IHL Annual General Meeting Date
07/10/22		138.04KB	Share
IHL Appendix 4G
20/09/22		263.2KB	Share
IHL Annual Report
20/09/22		18MB	Share
IHL Incannex Presenting at H.C. Wainwright Global Conference
08/09/22		148.95KB	Share
IHL Incannex Included in the S&P/ASX 300 Index
06/09/22		148KB	Share
IHL S&P DJI Announces September 2022 Quarterly Rebalance
02/09/22	PRICE SENSITIVE	134KB	Share
IHL Appendix 4E & Unaudited Accounts for Year Ended 30 June 2022
31/08/22	PRICE SENSITIVE	414.66KB	Share
IHL Appendix 3Y
26/08/22		275.45KB	Share
IHL Appendix 3X, Form 605 and Appendix 3Y
19/08/22		731.83KB	Share
IHL Incannex Appoints Distinguished FDA Expert to Board
17/08/22		159.23KB	Share

REFRESH

1 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

INCANNEX HEALTHCARE LIMITED - Announcements

Announcements

Top Stories